-
Gadfly's Nisen: Valeant's 'Financial Wizardry' Doesn't Change The Long-Term Outlook
Thursday, March 23, 2017 - 10:53am | 415Valeant Pharmaceuticals Intl Inc (NYSE: VRX)'s refinancing announcement on Tuesday shouldn't be celebrated by investors, at least according to Gadfly's Max Nisen. Nisen noted Valeant's "financial wizardry" doesn't address Valeant's long-term $30 billion debt load although it may ease short-term...
-
Valeant's Post-Ackman Recovery Is Characterized By 'Less Money, More Problems'
Tuesday, March 21, 2017 - 10:02am | 421Billionaire investor Bill Ackman cut his losses in Valeant Pharmaceuticals Intl Inc (NYSE: VRX)'s stock so now is the time for both the company and hedge fund manager to move on. According to a Bloomberg report, Valeant's path forward is difficult and characterized by the company having less money...
-
Valeant's Laundry List: Products, Divestitures And Debt Load
Tuesday, January 10, 2017 - 10:59am | 396Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) soared higher by more than 13 percent Tuesday morning after the company agreed to sell multiple business units as part of an ongoing initiative to pay down its debt load, which has some Wall Street analysts deeply concerned. Valeant has agreed...
-
Is Allergan Going After Valeant's Eye Surgery Assets?
Friday, November 18, 2016 - 12:47pm | 222It is no secret that Valeant Pharmaceuticals Intl Inc (NYSE: VRX) needs to divest some of its assets to give the company sufficient liquidity to reduce its debt load before it becomes potentially unmanageable. The Wall Street Journal reported in early November that the pharmaceutical company has...
-
Valeant Says Delayed 10-K Resulted In Several Notices Of Defaults
Monday, April 25, 2016 - 10:29am | 184Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced on Friday it has received several notices of defaults from trustees as a the result of its delayed 10-K filing. Valeant continued that the notices of default governing its 5.375 percent Senior Notes due 2020; 6.375 percent Senior...